Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-19

FDA Approved: BRIVARACETAM — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original abbreviated new drug application for brivaracetam from Novadoz Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIVARACETAM (brivaracetam)

Snippet

ORIG AP for BRIVARACETAM (BRIVARACETAM)